Human reproduction
-
Randomized Controlled Trial Comparative Study
Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
Can controlled ovarian stimulation with low-dose human menopausal gonadotrophin (hMG) improve the clinical pregnancy rate when compared with ovarian stimulation with clomiphene citrate (CC) in an intrauterine insemination (IUI) programme for subfertile couples? ⋯ T.M.D. and K.P. were supported by the Clinical Research Foundation of UZ Leuven, Belgium. This study was also supported by the Ferring company (Copenhagen, Denmark) which provide free medication (Menopur) required for the group of patients who were randomized in the hMG COS group. The Ferring company was not involved in the study design, data analysis, writing and submission of the paper.
-
Randomized Controlled Trial Multicenter Study
Improving patient-centredness in partnership with female patients: a cluster RCT in fertility care.
-
Do women treated with ovarian stimulation for IVF have an increased risk of melanoma? ⋯ This study was supported by grants from the Dutch Cancer Society (NKI 2006-3631), the Health Research and Development Counsel (28-2540) and the Dutch Ministry of Health.
-
What is the measured prevalence and phenotype of spontaneous premature ovarian failure (POF) in the general population? ⋯ The study was funded by grant SF0180044s09, SF0180027s10 and IUT20-43 from the Estonian Ministry of Education and Research, Enterprise Estonia, grant no EU30020, Eureka's EUROSTARS programme grant (NOTED, EU41564). No competing interests are declared.
-
Is a history of three or more miscarriages associated with adverse perinatal outcomes in a subsequent pregnancy? ⋯ There was no specific funding obtained for this study and there are no conflict of interests.